By using this site, you agree to the Privacy Policy and Terms of Use.
Accept

Theindiabizz

Startup and Entrepreneurship Stories, as well as a Leadership Story

  • Explore
    • India
    • Business
    • Venture capital
    • Private equity
    • Product Roadmap
  • News
    • Market
    • acquisition
    • Funding
    • energy
    • Automobile
  • Industry
    • Beauty Sector
    • Entertainment
    • Hotel Industry
    • Enterprise IT
    • Property
    • Consumer Internet
    • Tech
    • E commerce
    • Agency
    • Edtech startup
    • Banking Sector
  • Health
  • Leadership
Search
More
  • Her Story
  • Interview
  • Art And Culture News
  • Women Power
  • cryptocurrency
  • current affairs
  • Investor Pitch Deck
  • List of Indian VCs
  • List Of Investors In India
  • pr-newswire
  • Press release
  • Raise fund
  • Submit Startup
  • Government
  • Economy
  • Entertainment
  • Sport
  • Property
Reading: Fluidigm’s FDA-EUA Authorized Saliva-based SARS-CoV-2 RT-PCR Assay – Now for use in India
Share
Notification Show More
Latest News
TPG backed InsurTech PolicyBoss closes Series B with India SME Investments amongst a consortium of investors
TPG backed InsurTech PolicyBoss closes Series B with India SME Investments amongst a consortium of investors
June 6, 2023
Indian cricketer KL Rahul becomes an investor in HyugaLife, a startup backed by Sequoia.
Indian cricketer KL Rahul becomes an investor in HyugaLife, a startup backed by Sequoia.
June 6, 2023
Rs 280 Cr Vanished As Another Indian Startup Founder Enjoyed Lavish Lifestyle
Rs 280 Cr Vanished As Another Indian Startup Founder Enjoyed Lavish Lifestyle
June 4, 2023
Bengaluru landlord makes a noteworthy move by investing $10,000 in their tenant's startup
Bengaluru landlord makes a noteworthy move by investing $10,000 in their tenant’s startup
June 4, 2023
Spectacom Global has successfully raised Rs 11 crore in pre-Series A funding
Spectacom Global has successfully raised Rs 11 crore in pre-Series A funding
June 2, 2023
Aa
Aa
TheindiabizzTheindiabizz
  • Business
  • Politics
  • Funding
  • Health
  • Science
  • Fashion
  • acquisition
  • Agency news
  • Beauty Sector
Search
  • Explore
    • India
    • Business
    • Venture capital
    • Private equity
    • Product Roadmap
  • News
    • Market
    • acquisition
    • Funding
    • energy
    • Automobile
  • Industry
    • Beauty Sector
    • Entertainment
    • Hotel Industry
    • Enterprise IT
    • Property
    • Consumer Internet
    • Tech
    • E commerce
    • Agency
    • Edtech startup
    • Banking Sector
  • Health
  • Leadership
Have an existing account? Sign In
Follow US
Business

Fluidigm’s FDA-EUA Authorized Saliva-based SARS-CoV-2 RT-PCR Assay – Now for use in India

Editor Desk
By Editor Desk Published December 24, 2020
Last updated: 2020/12/24 at 2:59 PM
Share
SHARE

It’s been a year now since the first few human cases of COVID-19 infection were reported amidst the busy wholesale food market of China’s Wuhan city (1). The disease caused by SARS-CoV-2 virus, thought to have its origin in Bats, soon spread to cause worldwide outbreaks & escalated to a global pandemic. The latest statistics indicate 46.5 Million cases reported to date worldwide with the global mortality rate around 2.5% and India ranking second at 8.23M cases till date (2).

COVID-19 has brought with it the need for SARS-CoV-2 tracking, surveillance & diagnosis. Countries that adopted testing strategies early on were able to test, track & isolate individuals that showed disease symptoms & hence were better able to contain the disease spread. While antibody testing was initially taken up for screening, it was soon evident that Real-time PCR alone had the power for accurate diagnosis, making it the gold-standard confirmatory test for SARS-CoV2. At the start, the sample collection process for RT-PCR testing involved painful & inconvenient nasopharyngeal/oropharyngeal swab collection. This requires skilled technicians, who would additionally run the risk of exposure. This has even led to a couple of neo-natal deaths in India, due to inappropriate sample collection (3).

- Advertisement -

More recently, saliva-based testing methods are gaining popularity after studies suggested saliva specimens and nasopharyngeal swab specimens have similar sensitivity in the detection of SARS-CoV-2 (4).

Fluidigm’s Advanta Dx SARS-COV-2 RT-PCR kit is a saliva based diagnostic test (5). This kit facilitates SARS-CoV-2 detection from saliva samples easing the sample collection process & eliminating the need for Viral RNA extraction process. The kit is compatible with Fluidigm’s high-throughput Biomark HD platform. Fluidigm claims that with certain configurations, the Biomark HD system can run a maximum of 6000 samples & controls per day. Modular workflow supports concurrent parallel runs to achieve high throughput (6).

This FDA-EUA approved kit has also now received DCGI-CDSCO license for use in India by ICMR approved testing labs as per their guidelines. This test kit from Fluidigm is sold & marketed by Premas Lifesciences Pvt Ltd, New Delhi in India.

With schools, colleges, corporate offices opening up, saliva-based testing using Biomark HD can add great value for faster, non-invasive & safer testing. Several universities in the US have already started utilizing Fluidigm’s saliva-based assays & Biomark HD for testing their students (7). Fluidigm is also a recipient of a prestigious NIH-RADx grant. The RADx initiative fast-tra